A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia.

被引：0
|
作者：
Stein, Anthony Selwyn
Jongen-Lavrencic, Mojca
Garciaz, Sylvain
Huls, Gerwin A.
Maiti, Abhishek
Boissel, Nicolas
De Botton, Stephane
Fleming, Shaun
Zwaan, C. Michel
de Leeuw, David C.
Desai, Pinkal
Arellano, Martha Lucia
Avigan, David
Langemeijer, Saskia
Jensen, Kyle A.
Wagenaar, Timothy
Mi, Gu
Abbadessa, Giovanni
Bajel, Ashish
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Erasmus MC, Rotterdam, Netherlands
[3] Aix Marseille Univ, Inst Paoli Calmettes, Marseille, France
[4] Univ Med Ctr Groningen, Groningen, Netherlands
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[6] Hop St Louis, Paris, France
[7] Inst Gustave Roussy, Paris, France
[8] Alfred Hlth, Melbourne, Australia
[9] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[10] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[11] Weill Cornell Med, New York, NY USA
[12] Emory Univ, Atlanta, GA USA
[13] Beth Israel Deaconess Med Ctr, Boston, MA USA
[14] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[15] Sanofi, Cambridge, MA USA
[16] Peter MacCallum Canc Ctr, Melbourne, Australia
[17] Royal Melbourne Hosp, Melbourne, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7005
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Queudeville, Manon
    Schlegel, Patrick
    Heinz, Amadeus T.
    Lenz, Teresa
    Doering, Michaela
    Holzer, Ursula
    Hartmann, Ulrike
    Kreyenberg, Hermann
    von Stackelberg, Arend
    Schrappe, Martin
    Zugmaier, Gerhard
    Feuchtinger, Tobias
    Lang, Peter
    Handgretinger, Rupert
    Ebinger, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 473 - 483
  • [22] Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab
    Queudeville, Manon
    Handgretinger, Rupert
    Ebinger, Martin
    ONCOTARGETS AND THERAPY, 2017, 10 : 3567 - 3578
  • [23] Blinatumomab: A ray of hope for relapsed/refractory adult B-cell acute lymphoblastic leukemia
    Kapoor, Akhil
    Rajput, Prakash Singh
    Beniwal, Surender
    Kumar, Harvindra Singh
    CLINICAL CANCER INVESTIGATION JOURNAL, 2014, 3 (06): : 577 - 578
  • [24] Distinct Expression Patterns of CD123 and CD34 on Hematogones and Blasts in Precursor B-Cell Acute Lymphoblastic Leukemia
    Hassanein, N. M.
    Buckley, P. J.
    Lagoo, A. S.
    MODERN PATHOLOGY, 2009, 22 : 266A - 266A
  • [25] Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
    Anthony Stein
    Janet L. Franklin
    Victoria M. Chia
    Deborah Arrindell
    William Kormany
    Jacqueline Wright
    Mandy Parson
    Hamid R. Amouzadeh
    Jessica Choudhry
    Guiandre Joseph
    Drug Safety, 2019, 42 : 587 - 601
  • [26] Treatment of relapsed and refractory acute myeloid leukemia (MDS transformation) with CD123 chimeric antigen receptor T cell and literature review
    Ning, Y.
    Guo, X.
    Ren, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1729 - 1729
  • [27] Chromatin accessibility landscape of pediatric high-risk B-cell acute lymphoblastic leukemia
    Wang, Han
    Sun, Huiying
    Liang, Bilin
    Zhang, Fang
    Yang, Fan
    Cui, Bowen
    Ding, Lixia
    Wang, Ronghua
    Tang, Yanjing
    Rao, Jianan
    Hu, Wenting
    Zhao, Shuang
    Wu, Wenyan
    Li, Benshang
    Tang, Jingyan
    Shen, Shuhong
    Liu, Yu
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia
    Queudeville, Manon
    Stein, Anthony S.
    Locatelli, Franco
    Ebinger, Martin
    Handgretinger, Rupert
    Goekbuget, Nicola
    Gore, Lia
    Zeng, Yi
    Gokani, Priya
    Zugmaier, Gerhard
    Kantarjian, Hagop M.
    CANCER, 2023, 129 (09) : 1384 - 1393
  • [29] Benefit-Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
    Stein, Anthony
    Franklin, Janet L.
    Chia, Victoria M.
    Arrindell, Deborah
    Kormany, William
    Wright, Jacqueline
    Parson, Mandy
    Amouzadeh, Hamid R.
    Choudhry, Jessica
    Joseph, Guiandre
    DRUG SAFETY, 2019, 42 (05) : 587 - 601
  • [30] Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
    Mueller, Karen Thudium
    Grupp, Stephan A.
    Maude, Shannon L.
    Levine, John E.
    Pulsipher, Michael A.
    Boyer, Michael W.
    August, Keith J.
    Myers, G. Doug
    Tam, Constantine S.
    Jaeger, Ulrich
    Foley, Stephen Ronan
    Borchmann, Peter
    Schuster, Stephen J.
    Waller, Edmund K.
    Awasthi, Rakesh
    Potthoff, Bernd
    Warren, Andy
    Waldron, Edward R.
    McBlane, Fraser
    Chassot-Agostinho, Andrea
    Laetsch, Theodore W.
    BLOOD ADVANCES, 2021, 5 (23) : 4980 - 4991
12345